Phoenix, AZ / Munich, GERMANY – October 24, 2011 – Mission3 (www.mission3.com), the premier Regulatory Information Management software provider for the Life Sciences industry, today announced its acquisition of Munich, Germany-based GRS4 GmbH (www.grs4.de) to better service their respective clients coping with the challenges associated with meeting global regulatory compliance standards and international submission planning and tracking processes.
The combined solution offered by Mission3 and GRS4 will expedite the complex regulatory affairs and submission process with tools that substantially ease correspondence management, planning and tracking, project and product management from concept-to-market, and enhanced group collaboration to better tackle marketing authorizations, regulatory correspondence, clinical commitments and post-market maintenance.
“This acquisition with GRS4 promises to greatly benefit customers and partners alike,” said Dirk Beth, Mission3 President and CEO. “Not only does GRS4 bring experienced talent, a European base of operations and hundreds of customer contacts to the table, but its business expertise with diverse international regulatory standards promises to blast open a vast reserve of untapped business potential with our combined technologies.”
“Regulatory business intelligence management is a highly complex issue that demands connectivity instead of re-keying of data, a worldwide single platform instead of countless isolated solutions, and real-time analysis at the push of a button instead of the need for creating projects to gather single ad-hoc reports for a management request,” said Andreas Suchanek, newly appointed Chairman.
“Mission3 offers a Microsoft Sharepoint-based solution called GlobalTrack, which life science companies worldwide will successfully embrace because these companies struggle for insight and oversight of tough regulatory management issues,” said Beth. “Mission3 and GRS4 combined solutions will maximize productivity and shorten time-to-market.” Mission3 GlobalTrack supports the management of regulatory correspondence, planning and tracking of regulatory affairs milestones for clinical trials and marketing authorizations, renewals, and variations. It provides the product specific global status of marketing authorizations that must be submitted to health authorities as part of marketing authorization applications or as part of Pharmacovigilance reports.
Most recently, Mission3 was selected as one of 160 “High Potential Managed Partners” out of Microsoft’s more than 20,000 total partners chosen to provide unique solutions for vertical markets, such as Life Sciences, with solutions built upon Microsoft’s technology platforms.
About Mission3, Inc.
Mission3 is the premier Regulatory Information Management software company for the Life Sciences industry. Mission3’s solution includes electronic document management solutions for managing regulatory, clinical and corporate documents; Virtual Data Rooms to securely manage the due-diligence process for M&A and partnerships; full regulatory submission management that includes support for eCTD, 510(k), as well as paper and electronic publishing to compliment submission and dossier management. Topping off this extensive list of solutions to the Life Science industry is Mission3 GlobalTrack, a business intelligence platform that provides companies increase visibility into their global regulatory initiatives. Mission3 is a Microsoft Gold ISV and High Potential Managed Partner. For more information, visit www.mission3.com.
Press Contact:
Ali Tate
Marketing and Media Specialist
Mission3, Inc.
602.957.2150 ex. 1006
atate@mission3.com
Twitter: ali_tate
